Products for Research Use Only
RegisterLogin

Sontuzumab

CAT: 0804-HY-P99591-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99591-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sontuzumab (AS1402) is a humanizedised IgG1κ MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer[1].
CAS Number
372075-37-1
Product Name Alternative
AS1402; huHMFG-1
UNSPSC
12352203
Target
Mucin
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sontuzumab.html
Purity
99.66
Solubility
H2O
Smiles
[Sontuzumab]
Molecular Weight
(145.38 kDa)
References & Citations
[1]Pegram MD, et al. Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer. Breast Cancer Res. 2009;11 (5) :R73.|[2]Snijdewint FG, et al. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int J Cancer. 2001 Jul 1;93 (1) :97-106.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5819977Sontuzumab
GTR18398868-01Sontuzumab Antibody
HB102026-01Research Grade Sontuzumab
592206Sontuzumab (MUC1, CD227)
E55B0422Sontuzumab (Reference antibody)
ICH5876-1mgSontuzumab Biosimilar - Research Grade
GTR18697790-01Sontuzumab Human Monoclonal Antibody
A135017Sontuzumab Biosimilar (Monoclonal, IgG1-nd)
10-269Sontuzumab (MUC1/CD227) - Research Grade Biosimilar
YR1163-01Anti-Human CD227 Recombinant Antibody (Sontuzumab)

Popular Products